UAB CF Center

😀

[Organoid News @organoidscience]

👨‍⚕️ Researchers from @KU_Leuven studied cystic fibrosis transmembrane conductance regulator (CFTR) function in #organoids of subjects with common and rare CFTR mutations.

https://t.co/BBLiyXkqid

[Vertex Pharmaceuticals @VertexPharma]

Vertex Announces Positive Phase 3 data for one of our #cysticfibrosis medicines. Learn more: https://t.co/lfl3qlVFES

[UAB CF Center @UAB_CF_Center]

Images of the Year in Pulmonary Disease: Ferret Lung COPD imaging
#COPD #ferretlung #images

[Cystic Fibrosis Foundation @CF_Foundation]

The Foundation has awarded up to $1.61 million to Eloxx Pharmaceuticals Inc. to conduct an early Phase 2 clinical trial of an investigational drug that could potentially treat people with #cysticfibrosis who have a nonsense mutation. #CFresearch https://t.co/1hgzoC8JIT

[UAB CF Center @UAB_CF_Center]

UAB CF center recruiting patients with CF nonsense mutations to study the beneficial effect of Symdeko "Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations"
Link:https://t.co/Nl6LR242aS

[UAB CF Center @UAB_CF_Center]

@stevenmrowe

[UAB CF Center @UAB_CF_Center]

Innovative tool gives researchers new look at the nasal airway in CF patients https://t.co/DdAJJj2tIn

[UAB CF Center @UAB_CF_Center]

Eloxx Pharmaceuticals Will Launch Phase 2 ELX-02 Trial for CF Patients Carrying G542X Mutation https://t.co/V8AdaGNwFs

[Cystic Fibrosis Foundation @CF_Foundation]

Vertex announced today that it will seek @US_FDA approval for its CFTR modulator VX-445 combined with tezacaftor/ivacaftor in the third quarter.

If approved, the drug could eventually benefit more than 90% of people with #cysticfibrosis. #CFresearch https://t.co/8hoaflGUSM

[CF News Today @CFNewsToday]

Mutation in CFTR Gene Affects the Body’s Inner Clock, Mouse Study Suggests https://t.co/v9a47rNg1t

[UAB CF Center @UAB_CF_Center]

Exciting news to CF patients..:)

[Cystic Fibrosis Foundation @CF_Foundation]

Today, Vertex released positive results from two ongoing, late-stage clinical trials for the potential VX-445 triple combination therapy. #CFresearch https://t.co/X6Jn4zZKtq

[Emily's Entourage @EmilysEntourage]

Honored to be featured in a beautifully written @statnews article this morning showcasing the 10% of the CF community without life-saving therapeutics. Thank you @DrewQJoseph & everyone who took part! READ MORE> https://t.co/uQn3KH9TVi #cureCF #cfaware #patientadvocacy

[Matthew S. Alexander @Matt_Muscle_Guy]

#3. Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy #Science https://t.co/dOwMyCm2ma There's still concerns over off-target effects, Cas9 T-cell immunoreactivity, & the long-term effects, but the field will likely move forward in 2019.

[UAB CF Center @UAB_CF_Center]

UAB CF center recruiting patients with two copies of W1282X mutations to study the beneficial effect of Symdeko "Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations"
Link: https://t.co/kHHYRspuP9

[Daniel MacArthur @dgmacarthur]

Where to go for rare disease diagnoses after exome sequencing fails? Excellent review of the options by @LaureFresard and @sbmontgom: https://t.co/toJKZytgPj

[UAB Pulmonary @UABPulmonary]

An excellent piece on modern #cysticfibrosis research and treatment at UAB. We're very proud of the work done by the entire @UAB_CF_Center team! https://t.co/R5qIdejvCW

[UAB CF Center @UAB_CF_Center]

UAB presence at "Therapeutic Development for Nonsense Mutations: The Final Frontier of CF" EE symposium held at Wistar institute, Philadelphia.

[Emily's Entourage @EmilysEntourage]

We held our 2018 Scientific Symposium “Therapeutic Development for Nonsense Mutations: The Final Frontier of CF” on September 25 at @TheWistar in Philadelphia and we’re super excited to provide you with a recap in our latest blog! https://t.co/o3AN6QVvdr #cureCF #beatCF #EE

[UAB CF Center @UAB_CF_Center]

Congratulations Steve and Susan for being part of this discovery.
A previously unknown airway cell type may be a key to efforts to cure cystic fibrosis
https://t.co/oYuC74IT4L

[UAB CF Center @UAB_CF_Center]

Lung cell discovery opens new route for cystic fibrosis treatment https://t.co/YcXBRYzR76